Polar Capital Holdings’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77.4M | Sell |
|
|||||
|
2025
Q1 | $75.6M | Sell |
|
|||||
|
2024
Q4 | $72.9M | Hold |
|
|||||
|
2024
Q3 | $85.3M | Buy |
|
|||||
|
2024
Q2 | $69.3M | Buy |
|
|||||
|
2024
Q1 | $35.1M | Buy |
|
|||||
|
2023
Q4 | $35.4M | Sell |
|
|||||
|
2023
Q3 | $41.6M | Hold |
|
|||||
|
2023
Q2 | $44.6M | Sell |
|
|||||
|
2023
Q1 | $62.5M | Buy |
|
|||||
|
2022
Q4 | $70.7M | Buy |
|
|||||
|
2022
Q3 | $23K | Sell |
|
|||||
|
2022
Q2 | $31.1K | Sell |
|
|||||
|
2022
Q1 | $37.5K | Sell |
|
|||||
|
2021
Q4 | $90.8K | Buy |
|
|||||
|
2021
Q3 | $98.9K | Buy |
|
|||||
|
2021
Q2 | $55.6K | Buy |
|
|||||
|
2021
Q1 | $28M | Sell |
|
|||||
|
2020
Q4 | $26.3M | Buy |
|